Cargando…

Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)

3-iodothyronamine (T1AM) and 3-iodothyroacetic acid (TA1) are thyroid-hormone-related compounds endowed with pharmacological activity through mechanisms that remain elusive. Some evidence suggests that they may have redox features. We assessed the chemical activity of T1AM and TA1 at pro-oxidant con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gencarelli, Manuela, Lodovici, Maura, Bellusci, Lorenza, Raimondi, Laura, Laurino, Annunziatina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910694/ https://www.ncbi.nlm.nih.gov/pubmed/35269859 http://dx.doi.org/10.3390/ijms23052718

Ejemplares similares

Brain Histamine Modulates the Antidepressant-Like Effect of the 3-Iodothyroacetic Acid (TA1)
por: Laurino, Annunziatina, et al.
Publicado: (2019)

3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes
por: Gencarelli, Manuela, et al.
Publicado: (2020)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism
por: Laurino, Annunziatina, et al.
Publicado: (2018)

Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases
por: Laurino, Annunziatina, et al.
Publicado: (2018)

Exogenous 3-Iodothyronamine (T(1)AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA(1))
por: Bandini, Lavinia, et al.
Publicado: (2022)

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway
por: Rogowski, Michael, et al.
Publicado: (2019)

Commentary: Euthyroid Sick Syndrome in Patients With COVID-19
por: Laurino, Annunziatina, et al.
Publicado: (2021)

Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue
por: Landucci, Elisa, et al.
Publicado: (2019)

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020)

Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2023)

Commentary: Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut—From Gut to Brain?
por: Laurino, Annunziatina, et al.
Publicado: (2017)

Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)
por: Haiyan, Zhou, et al.
Publicado: (2020)

Substantial impact of 3-iodothyronamine (T1AM) on the regulations of fluorescent thermoprobe-measured cellular temperature and natriuretic peptide expression in cardiomyocytes
por: Takahashi, Hirotake, et al.
Publicado: (2022)

Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling
por: D’Ambrosio, Mario, et al.
Publicado: (2023)

Thyroid Homeostasis: An Intricate Network of Production, Transport, Metabolism and Receptors Interaction
por: Laurino, Annunziatina, et al.
Publicado: (2022)

Modulation of cardiac ionic homeostasis by 3-iodothyronamine
por: Ghelardoni, Sandra, et al.
Publicado: (2009)

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression
por: Assadi-Porter, Fariba M., et al.
Publicado: (2018)

Effect of Combined Levothyroxine (L-T(4)) and 3-Iodothyronamine (T(1)AM) Supplementation on Memory and Adult Hippocampal Neurogenesis in a Mouse Model of Hypothyroidism
por: Rutigliano, Grazia, et al.
Publicado: (2023)

Update on 3-iodothyronamine and its neurological and metabolic actions
por: Zucchi, Riccardo, et al.
Publicado: (2014)

Thyroid Hormone Metabolite 3-Iodothyronamine (T1AM) Alleviates Hypoxia/Reoxygenation-Induced Cardiac Myocyte Apoptosis via Akt/FoxO1 Pathway
por: Zhou, Haiyan, et al.
Publicado: (2020)

Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T(1)AM) in Human Corneal Keratocytes
por: Türker, Ersal, et al.
Publicado: (2018)

Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways
por: Laurino, Annunziatina, et al.
Publicado: (2019)

Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern
por: Mariotti, Veronica, et al.
Publicado: (2014)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine
por: Zhang, Xiaoqun, et al.
Publicado: (2018)

Uptake of 3‐iodothyronamine hormone analogs inhibits the growth and viability of cancer cells
por: Rogowski, Michael, et al.
Publicado: (2017)

The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor
por: Bräunig, Julia, et al.
Publicado: (2018)

Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5
por: Dinter, Juliane, et al.
Publicado: (2015)

3-Iodothyronamine Activates a Set of Membrane Proteins in Murine Hypothalamic Cell Lines
por: Bräunig, Julia, et al.
Publicado: (2018)

3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?
por: Khajavi, Noushafarin, et al.
Publicado: (2017)

Behavioral hypothermia of a domesticated lizard under treatment of the hypometabolic agent 3-iodothyronamine
por: Ha, Kyoungbong, et al.
Publicado: (2016)

3-iodothyronamine inhibits apoptosis induced by myocardial ischemia reperfusion via the Akt/FoxO1 signaling pathway
por: Zhou, Haiyan, et al.
Publicado: (2022)

TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells
por: Walcher, Lia, et al.
Publicado: (2018)

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine
por: Selen Alpergin, Ebru S., et al.
Publicado: (2017)

INdAM conference "CoMeTA 2013 - Combinatorial Methods in Topology and Algebra"
por: Benedetti, Bruno, et al.
Publicado: (2015)

Sulindac, 3,3’-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis
por: Femia, Angelo Pietro, et al.
Publicado: (2015)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Oxidative Stress and Air Pollution Exposure
por: Lodovici, Maura, et al.
Publicado: (2011)

Biomarkers of Induced Active and Passive Smoking Damage
por: Lodovici, Maura, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8dlvaku6dvec8p7mgqu40omofv